Related references
Note: Only part of the references are listed.Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology
Nicolas Dzamko et al.
ACTA NEUROPATHOLOGICA (2017)
Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses
Rosa Calvello et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Neuroprotective Effects of Loganin on MPTP-Induced Parkinson's Disease Mice: Neurochemistry, Glial Reaction and Autophagy Studies
Yi-Da Xu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson's Disease
Goutam Chandra et al.
JOURNAL OF IMMUNOLOGY (2017)
Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation
Qiu-Shuang Zhang et al.
TOXICOLOGY LETTERS (2017)
Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's Disease
Sandeep More et al.
NUTRIENTS (2017)
Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway
Haoran Jing et al.
PLOS ONE (2017)
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2
Michela Campolo et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease
Young C. Chung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders
Swati Agarwal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Microglial M1/M2 polarization and metabolic states
Ruben Orihuela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation
Emiliano Pena-Altamira et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease
Anamitra Ghosh et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Increased Peripheral Inflammation in Asymptomatic Leucine-Rich Repeat Kinase 2 Mutation Carriers
Nicolas Dzamko et al.
MOVEMENT DISORDERS (2016)
Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra
Yang Heng et al.
TOXICOLOGY LETTERS (2016)
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
Hayate Javed et al.
FRONTIERS IN NEUROSCIENCE (2016)
Vagotomy and Subsequent Risk of Parkinson's Disease
Elisabeth Svensson et al.
ANNALS OF NEUROLOGY (2015)
Roles of microglia in brain development, tissue maintenance and repair
Mackenzie A. Michell-Robinson et al.
BRAIN (2015)
New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis
Clayton English et al.
CLINICAL THERAPEUTICS (2015)
Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model
Wei Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
Joao P. L. Daher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease
Shaoxia Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2015)
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. (vol 14, pg 795, 2015)
Chadwick W. Christine
LANCET NEUROLOGY (2015)
Clinical correlation of peripheral CD4+-cell sub-sets, their imbalance and Parkinson's disease
Yuhua Chen et al.
MOLECULAR MEDICINE REPORTS (2015)
α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease
Byung-Wook Kim et al.
NEUROPHARMACOLOGY (2015)
M1 AND M2 IMMUNE ACTIVATION IN PARKINSON'S DISEASE: FOE AND ALLY?
M. S. Moehle et al.
NEUROSCIENCE (2015)
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson's disease
Maria Concepcion Garcia et al.
NEUROSCIENCE LETTERS (2015)
Diversity and plasticity of microglial cells in psychiatric and neurological disorders
Yutaka Nakagawa et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Alternatively activated microglia and macrophages in the central nervous system
Rafael Franco et al.
PROGRESS IN NEUROBIOLOGY (2015)
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
Salvador Sierra et al.
BRAIN STRUCTURE & FUNCTION (2015)
Induction of GDNF and BDNF by hRheb(S16H) Transduction of SNpc Neurons: Neuroprotective Mechanisms of hRheb(S16H) in a Model of Parkinson's Disease
Jin Han Nam et al.
MOLECULAR NEUROBIOLOGY (2015)
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Tanya Simuni et al.
LANCET NEUROLOGY (2015)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
The future of JAK inhibition in myelofibrosis and beyond
John O. Mascarenhas et al.
BLOOD REVIEWS (2014)
Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease
Y. Tang et al.
CELL DEATH AND DIFFERENTIATION (2014)
CD200R1 and CD200 expression are regulated by PPAR-γ in activated glial cells
Guido Dentesano et al.
GLIA (2014)
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Debora Giunti et al.
IMMUNOLOGY (2014)
Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of Experimental Autoimmune Encephalomyelitis
Yudong Liu et al.
JOURNAL OF IMMUNOLOGY (2014)
Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
Hugo Gonzalez et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
Diana Fernandez-Suarez et al.
NEUROBIOLOGY OF AGING (2014)
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
Augusta Pisanu et al.
NEUROBIOLOGY OF DISEASE (2014)
Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease
Maciej Świątkiewicz et al.
Pharmacological Reports (2014)
The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease
Ilona Joniec-Maciejak et al.
PHARMACOLOGICAL REPORTS (2014)
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Joao P. L. Daher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Monocytes and macrophages: developmental pathways and tissue homeostasis
Florent Ginhoux et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro
Vibol Chhor et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Caudo-rostral brain spreading of α-synuclein through vagal connections
Ayse Ulusoy et al.
EMBO MOLECULAR MEDICINE (2013)
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
Lisa Fellner et al.
GLIA (2013)
Microglial Activation and Antioxidant Responses Induced by the Parkinson's Disease Protein α-Synuclein
Dawn Beraud et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Fingolimod phosphate promotes the neuroprotective effects of microglia
Hiromi Noda et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Daphne Y. S. Vogel et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease
Natalja Funk et al.
MOVEMENT DISORDERS (2013)
Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol
Mohammad Moshahid Khan et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Microglia Multiple roles in surveillance, circuit shaping, and response to injury
Eduardo E. Benarroch
NEUROLOGY (2013)
Review: Activation patterns of microglia and their identification in the human brain
D. Boche et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia
Paul Edison et al.
NEUROPSYCHOPHARMACOLOGY (2013)
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease
S. Iannaccone et al.
PARKINSONISM & RELATED DISORDERS (2013)
Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia
Robert W. Freilich et al.
PLOS ONE (2013)
Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation
Cintia Roodveldt et al.
PLOS ONE (2013)
Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease
Joanna Schwenkgrub et al.
PHARMACOLOGICAL REPORTS (2013)
Factors regulating microglia activation
Katrin Kierdorf et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
The role of LRRK2 in inflammatory bowel disease
Zhihua Liu et al.
CELL RESEARCH (2012)
Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein
Melanie B. Watson et al.
EXPERIMENTAL NEUROLOGY (2012)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Defining GM-CSF- and Macrophage-CSF Dependent Macrophage Responses by In Vitro Models
Derek C. Lacey et al.
JOURNAL OF IMMUNOLOGY (2012)
CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease
Jessica A. Hutter Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
Shweta Mandrekar-Colucci et al.
JOURNAL OF NEUROSCIENCE (2012)
AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon Regrowth
Sang Ryong Kim et al.
MOLECULAR THERAPY (2012)
LONG-TERM POLARIZATION OF MICROGLIA UPON α-SYNUCLEIN OVEREXPRESSION IN NONHUMAN PRIMATES
P. Barkholt et al.
NEUROSCIENCE (2012)
A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (Line 61) Mice
Marie-Francoise Chesselet et al.
NEUROTHERAPEUTICS (2012)
Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice
Francisco Pan-Montojo et al.
SCIENTIFIC REPORTS (2012)
Dopaminergic Pathway Reconstruction by Akt/Rheb-Induced Axon Regeneration
Sang Ryong Kim et al.
ANNALS OF NEUROLOGY (2011)
Taming of macrophage and microglial cell activation by microRNA-124
Ashley T. Conrad et al.
CELL RESEARCH (2011)
Microglia Phenotype Diversity
M. Olah et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
NSAID use and risk of Parkinson disease: a population-based case-control study
C. Becker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice
A. Florence Keller et al.
EXPERIMENTAL NEUROLOGY (2011)
A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci
Andrew Singleton et al.
HUMAN MOLECULAR GENETICS (2011)
Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria
Saskia Schmidt et al.
HUMAN MOLECULAR GENETICS (2011)
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
Lalida Rojanathammanee et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
Jose L. Lanciego et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Delayed Dominant-Negative TNF Gene Therapy Halts Progressive Loss of Nigral Dopaminergic Neurons in a Rat Model of Parkinson's Disease
Ashley S. Harms et al.
MOLECULAR THERAPY (2011)
Use of ibuprofen and risk of Parkinson disease
Xiang Gao et al.
NEUROLOGY (2011)
ROSIGLITAZONE DECREASES PEROXISOME PROLIFERATOR RECEPTOR-GAMMA LEVELS IN MICROGLIA AND INHIBITS TNF-ALPHA PRODUCTION: NEW EVIDENCES ON NEUROPROTECTION IN A PROGRESSIVE PARKINSON'S DISEASE MODEL
A. R. Carta et al.
NEUROSCIENCE (2011)
Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice
Ravi S. Akundi et al.
PLOS ONE (2011)
Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region
Erin M. Hill-Burns et al.
PLOS ONE (2011)
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Rosa C. Paolicelli et al.
SCIENCE (2011)
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies
Karen Rees et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Nomenclature of monocytes and dendritic cells in blood
Loems Ziegler-Heitbrock et al.
BLOOD (2010)
Antioxidative and Anti-Inflammatory Protection from Carnosine in the Striatum of MPTP-Treated Mice
Shih-Jei Tsai et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
Parkinson's disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans
Elena M. Cornejo Castro et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease
Ruth F. Villaran et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation
Henrik Wilms et al.
JOURNAL OF NEUROINFLAMMATION (2010)
The Toll-Like Receptor-3 Agonist Polyinosinic:Polycytidylic Acid Triggers Nigrostriatal Dopaminergic Degeneration
Michela Deleidi et al.
JOURNAL OF NEUROSCIENCE (2010)
The myeloid cells of the central nervous system parenchyma
Richard M. Ransohoff et al.
NATURE (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
Role of Microglia in Neurotrauma
David J. Loane et al.
NEUROTHERAPEUTICS (2010)
Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
Francisco Pan-Montojo et al.
PLOS ONE (2010)
Changing Face of Microglia
Manuel B. Graeber
SCIENCE (2010)
Microglial Interactions with Synapses Are Modulated by Visual Experience
Marie-Eve Tremblay et al.
PLOS BIOLOGY (2010)
Parkinson's Disease The Dual Hit Theory Revisited
Christopher H. Hawkes et al.
INTERNATIONAL SYMPOSIUM ON OLFACTION AND TASTE (2009)
Debris clearance by microglia: an essential link between degeneration and regeneration
H. Neumann et al.
BRAIN (2009)
NSAID Use and the Risk of Parkinson's Disease Systematic Review and Meta-Analysis of Observational Studies
Ali Samii et al.
DRUGS & AGING (2009)
WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
David A. Price et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
Xiaoyu Hu et al.
IMMUNITY (2009)
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
Vanessa Brochard et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Differential gene expression in LPS/IFNγ activated microglia and macrophages: in vitro versus in vivo
Christoph D. Schmid et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-β
Alessandro Michelucci et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy
Chee Yeun Chung et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
Xiaomin Su et al.
NEUROTOXICITY RESEARCH (2009)
Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson's Disease by Blocking Microglial Activation
Minho Moon et al.
NEUROTOXICITY RESEARCH (2009)
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis
Danielle Burger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The influence of microglia on the pathogenesis of Parkinson's disease
Caitriona M. Long-Smith et al.
PROGRESS IN NEUROBIOLOGY (2009)
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results
Karl Kieburtz et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra
Hong Jiang et al.
EXPERIMENTAL NEUROLOGY (2008)
The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery
Garima Dutta et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Microglial cells and Parkinson's disease
Li Qian et al.
IMMUNOLOGIC RESEARCH (2008)
Production and functions of IL-17 in microglia
Jun Kawanokuchi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats
Melissa K. McCoy et al.
MOLECULAR THERAPY (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease?
R. J. Phillips et al.
NEUROSCIENCE (2008)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Angelika D. Wahner et al.
NEUROLOGY (2007)
Neurotransmitter receptors on microglia
Jennifer M. Pocock et al.
TRENDS IN NEUROSCIENCES (2007)
CD200 ligand-receptor interaction modulates microglial activation in vivo and in vitro:: A role for IL-4
Anthony Lyons et al.
JOURNAL OF NEUROSCIENCE (2007)
Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons
Inmaculada Rite et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly
J. Braun et al.
RHEUMATOLOGY (2007)
TNF-α knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice
Chaohui Zhao et al.
NEUROBIOLOGY OF DISEASE (2007)
Involvement of interferon-γ in microglial-mediated loss of dopaminergic neurons
Matthew P. Mount et al.
JOURNAL OF NEUROSCIENCE (2007)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
Marjolijn Bornebroek et al.
NEUROEPIDEMIOLOGY (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
α-synuclein expression modulates microglial activation phenotype
Susan A. Austin et al.
JOURNAL OF NEUROSCIENCE (2006)
Production of interferon-γ by microglia
J. Kawanokuchi et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1
Oleg Butovsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging
MG Frank et al.
NEUROBIOLOGY OF AGING (2006)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
Diverse microglial responses after intrahippocampal administration of lipopolysaccharide
DL Herber et al.
GLIA (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease
Bin Liu
AAPS JOURNAL (2006)
Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain
Emmanuel S. Onaivi
NEUROPSYCHOBIOLOGY (2006)
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor -: art. no. e65
S Goldwurm et al.
JOURNAL OF MEDICAL GENETICS (2005)
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
K Maresz et al.
JOURNAL OF NEUROCHEMISTRY (2005)
ATP mediates rapid microglial response to local brain injury in vivo
D Davalos et al.
NATURE NEUROSCIENCE (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
The MPTP model of Parkinson's disease
RJ Smeyne et al.
MOLECULAR BRAIN RESEARCH (2005)
CX(3)CL1 (fractalkine) and CX(3)CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
Dan Sunnemark et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
Emilie Croisier et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo
R Kortekaas et al.
ANNALS OF NEUROLOGY (2005)
Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: Implications for Alzheimer therapeutics
D Morgan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study
H Watanabe et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Therapeutic strategies for neurodegenerative disorders: Emerging clues from Parkinson's disease
CR Bjarkam et al.
BIOLOGICAL PSYCHIATRY (2004)
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
EJ Benner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation
T Dehmer et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Inflammation and neurodegeneration in Parkinson's disease
PL McGeer et al.
PARKINSONISM & RELATED DISORDERS (2004)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
DJ Mahad et al.
SEMINARS IN IMMUNOLOGY (2003)
Neuroinflammatory processes in Parkinson's disease
S Hunot et al.
ANNALS OF NEUROLOGY (2003)
Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease
K Sriram et al.
FASEB JOURNAL (2002)
Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease
HM Gao et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
YS Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum
Y He et al.
BRAIN RESEARCH (2001)
Share Paper
